Study on liver diseases with zebrafish as an important tool.
10.19540/j.cnki.cjcmm.20200916.601
- Author:
Zhi-Qi LI
1
;
Yue XU
1
;
Xia ZHAO
1
;
Zhe JIA
1
;
Zhao-Yi WANG
1
;
Dan FENG
1
;
Cui-Bai LI
2
;
Zhi-Qiang MA
1
;
Chong-Jun ZHAO
1
;
Rui-Chao LIN
1
Author Information
1. Beijing Key Laboratory of Chinese Medicine Quality Evaluation, College of Chinese Medicine, Beijing University of Chinese Medicine Beijing 102488, China.
2. De Hong Vocational College Dehong 678400, China.
- Publication Type:Journal Article
- Keywords:
drug screening and evaluation;
hepatotoxicity;
mechanism;
traditional Chinese medicine;
zebrafish
- MeSH:
Animals;
Drug Evaluation, Preclinical;
Humans;
Liver;
Liver Diseases/genetics*;
Medicine, Chinese Traditional;
Zebrafish/genetics*
- From:
China Journal of Chinese Materia Medica
2021;46(2):320-332
- CountryChina
- Language:Chinese
-
Abstract:
With the increasing incidence of hepatobiliary diseases, it is particularly important to understand the role of molecular, cellular and physiological factors in the clinical diagnosis and treatment with traditional Chinese medicine(TCM) in the development of liver disease. Appropriate animal models can help us identify the possible mechanisms of relevant diseases. Danio rerio(zebrafish) model was traditionally used to study embryonic development, and has been gradually used in screening and evaluation of liver diseases and relevant drug in recent years. Zebrafish embryos develop rapidly and the digestive organs of 5-day-old juvenile fish are all mature. At this stage, they may develop hepatobiliary diseases induced by developmental defects or compounds. Zebrafish liver is similar to human liver in cell composition, function, signal transduction, response to injury and cell process mediating liver disease. Furthermore, due to the high conservation of genes and proteins between humans and zebrafish, zebrafish becomes an alternative system for studying basic mechanisms of liver disease. Therefore, genetic screening could be performed to identify new genes involving specific disease processes, and chemical screening could be made for drugs in specific processes. This paper briefly introduced the experimental properties of zebrafish as model system, emphasized the study progress of zebrafish models for pathological mechanism of liver diseases, especially fatty liver, and drug screening and evaluation, so as to provide ideas and techniques for the future liver toxicity assessment of TCM.
